NCT07507721 Tele-Nursing-Supported Mindfetalness: Anxiety and Prenatal Attachment
| NCT ID | NCT07507721 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Abant Izzet Baysal University |
| Condition | Tele-nursing |
| Study Type | INTERVENTIONAL |
| Enrollment | 68 participants |
| Start Date | 2026-04-15 |
| Primary Completion | 2027-02-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 68 participants in total. It began in 2026-04-15 with a primary completion date of 2027-02-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare the effects of tele-nursing-supported Mindfetalness method versus Mindfetalness alone method on maternal anxiety and prenatal attachment in pregnant women. The main questions it aims to answer are: * H1: Tele-nursing-supported Mindfetalness method will significantly reduce state anxiety (STAI-S) levels in pregnant women over time compared to Mindfetalness alone method. * H2: Tele-nursing-supported Mindfetalness method will significantly reduce trait anxiety (STAI-T) levels in pregnant women over time compared to Mindfetalness alone method. * H3: Tele-nursing-supported Mindfetalness method will significantly increase prenatal attachment (PAI) levels in pregnant women over time compared to Mindfetalness alone method. Researches will compare tele-nursing-supported Mindfetalness to Mindfetalness alone to see if tele-nursing support significiantly reduces state and trait anxiety levels and significiantly increases prenatal attachment levels in pregnant women over time. Participants will; * Attend a single, face-to-face Mindfetalness training session at the beginning of the study to learn technique and application procedures correctly. * Practice Mindfetalness method daily for 15 minutes throughout the 8-week study period. * Complete a daily compliance tracking chart to record their adherence to the Mindfetalness method of their practice. * Complete the State-Trait Anxiety Inventory (STAI) and the Prenatal Attachment Inventory (PAI) at baseline and during 4th and 8th-week follow-up measurements to track changes over time.
Eligibility Criteria
Inclusion Criteria: * Aged 18 years or older * Being at the 28th week of gestation * Having a singleton pregnancy * Being primiparous * Being literate * Having access to and the ability to use a mobile device and internet connection (personal or via spouse) compatible with the tele-nursing application * Volunteering to participate in the study and providing informed consent (Araştırmaya katılmaya gönüllü olmak ve bilgilendirilmiş onam vermek) Exclusion Criteria: * Having a high-risk pregnancy (e.g., preterm labor threat, preeclampsia, gestational diabetes, placenta previa, or cardiac disease). * Presence of diagnosed fetal health complications (e.g., intrauterine growth restriction \[IUGR\], fetal anomalies). * Currently monitoring fetal movements using any other conventional fetal movement counting methods. * Presence of any communication barriers (e.g., hearing, speech, or language impairments). * History or current diagnosis of chronic or psychiatric illness. * Conception through assisted reproductive techniques (ART) (e.g., IVF).
Contact & Investigator
Nevin ÇITAK BİLGİN, Associate Professor, PhD
PRINCIPAL INVESTIGATOR
Abant Izzet Baysal University
Frequently Asked Questions
Who can join the NCT07507721 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Tele-nursing. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07507721 currently recruiting?
Yes, NCT07507721 is actively recruiting participants. Contact the research team at busra.boga@ibu.edu.tr for enrollment information.
Where is the NCT07507721 trial being conducted?
This trial is being conducted at Bolu, Turkey (Türkiye), Bolu, Turkey (Türkiye).
Who is sponsoring the NCT07507721 clinical trial?
NCT07507721 is sponsored by Abant Izzet Baysal University. The principal investigator is Nevin ÇITAK BİLGİN, Associate Professor, PhD at Abant Izzet Baysal University. The trial plans to enroll 68 participants.